Sumitomo Chemical Co., Ltd. (4005)

Currency in JPY
544.5
+206.5(+61.09%)
Closed·
Showing Sumitomo Chemical historical data. For real-time data please try another search
Day's Range
500.5614.5
52 wk Range
500.5614.5
Key Statistics
Prev. Close
338
Open
572
Day's Range
500.5-614.5
52 wk Range
541.5-548.5
Volume
9.49M
Average Volume (3m)
9.69M
1-Year Change
0%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy

Sumitomo Chemical Co., Ltd. Company Profile

Sumitomo Chemical Company, Limited engages in Agro & Life Solutions, ICT & Mobility Solutions, Advanced Medical Solutions, Essential & Green Materials, and Sumitomo Pharma. The Agro & Life Solutions segment offers crop protection chemicals, fertilizers, agricultural materials, household insecticides, products for control of infectious diseases, and feed additives, etc. The ICT & Mobility Solutions segment provides optical products, semiconductor processing materials, compound semiconductor materials, touch screen sensor panels, high-purity aluminum and alumina, specialty chemicals, additives, engineering plastics, and battery materials, etc. The Advanced Medical Solutions segment offers contract development and manufacturing organization business for small-molecule active ingredients and intermediates, oligonucleic acid drug substances, and regenerative medicine, and cell therapy products, etc. The Essential & Green Materials segment offers synthetic resins, raw materials for synthetic fibers, various industrial chemicals, methyl methacrylate products, synthetic resin processed products, industrial aluminum and alumina, and synthetic rubber, etc. The Sumitomo Pharma segment offers small molecule pharmaceuticals. Sumitomo Chemical Company, Limited was founded in 1913 and is headquartered in Tokyo, Japan.

Industry
Chemicals
Employees
29279
Market
Japan

Sumitomo Chemical Co., Ltd. Earnings Call Summary for Q1/2026

  • Core operating income rose 22 billion yen YoY to 27.7 billion yen, despite sales revenue declining 86 billion yen to 526.1 billion yen
  • Net income resulted in a 4.5 billion yen loss, with strong performance in pharma and crop protection offsetting challenges
  • H1 FY2025 forecast: 1,100 billion yen revenue, 90 billion yen core operating income, 25 billion yen net income
  • Strong yen expected to impact ICT and Mobility Solutions segments; pharma and essential materials anticipate profit growth
  • Company cites improving inventory levels and methionine market recovery, progressing on medium-term plan despite uncertainties
Last Updated: 14/10/2025, 23:16
Read Full Transcript

Analyst Ratings

5 Buy
6 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 0.0

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 5.92%
Dividend Yield
2.63%
Industry Median 2.42%
Annualised payout
12.00
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Aug 01, 2025
EPS / Forecast
-2.76 / --
Revenue / Forecast
526.14B / --
EPS Revisions
Last 90 days

4005 Income Statement

People Also Watch

2,694.5
1605
-0.42%
16,675.0
5803
-3.02%
160.1
9432
+0.69%
17,400.0
6857
-0.63%
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.